Log in to save to my catalogue

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgrou...

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgrou...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ab2392fa997b444d9aec48cb92757bfd

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial

About this item

Full title

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial

Publisher

London: BioMed Central

Journal title

Alzheimer's research & therapy, 2023-10, Vol.15 (1), p.1-183, Article 183

Language

English

Formats

Publication information

Publisher

London: BioMed Central

More information

Scope and Contents

Contents

BackgroundIn MAPT (Multidomain Alzheimer Preventive Trial), a cognitive effect of multidomain intervention (MI) was showed in non-demented subjects with positive amyloid PET. However, screening eligible patients for multidomain intervention by PET is difficult to generalize in real-world settings.MethodsMAPT study was a 3-year, randomized, placebo-...

Alternative Titles

Full title

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ab2392fa997b444d9aec48cb92757bfd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ab2392fa997b444d9aec48cb92757bfd

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-023-01325-3

How to access this item